GILD Gilead Sciences, Inc. | US3755581036
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 160.547.405.824 | 173.097.533.935,55 | 152.281.014.276,64 | 137.862.000.000 |
| Enterprise Value | 172.820.398.080 | 187.643.533.935,55 | 169.653.014.276,64 | 155.473.000.000 |
| Trailing P/E | 17,62 | 18,78 | 17,89 | 21,79 |
| Forward P/E | 13,43 | - | - | - |
| Price to Sales | 5,4 | 5,82 | 5,17 | 6,41 |
| Price to Book | 6,83 | 7,36 | 6,71 | 6,4 |
| EV/Revenue | 5,81 | 6,31 | 5,76 | 7,23 |
| EV/EBITDA | 11,73 | 12,51 | 11,46 | 14,09 |